Disease Concerns Point Out Benefits Of Laser Surgery For Back Pain
LOS ANGELES, Nov. 15, 2012 /PRNewswire/ -- Many back pain sufferers have become alarmed due to internationally reported news stories tracing October's meningitis outbreak to steroidal treatments for pain and other issues. Renowned orthopedic surgeon, Seyed M. Rezaian, M.D., Ph.D., F.R.C.S., F.I.C.S. strongly recommends using his trademark endoscopic discectomy technique to directly eliminate the causes of back pain. While steroids and other temporary stop gap measures may be attractive in the short term, the need for Southern California residents to visit outstanding medical facilities such as Dr. Rezaian's California Orthopaedic Medical Clinic to investigate permanent solutions to back pain has been bolstered by some widely publicized and frightening news.
More and more, it appears that endoscopic discectomy surgery is significantly preferable to steroid injections for a number of compelling reasons. News of a shocking and tragic outbreak of deadly fungal meningitis – most recently covered in Scientific American by writer Jennifer Frazer -- through steroid injections has rocked the medical world in recent weeks and worried countless patients. Also, steroidal injections, like most drug-based painkilling techniques, may be of limited value over and can often prove to be a failed back surgery treatment.
Awareness of a new possible danger related to steroidal painkillers and disease outbreaks was compounded by preliminary findings presented at the annual meeting of the North American Spine Society. The study appears to indicate that epidural steroid shots may significantly increase the risk of spinal bone fractures, particularly for patients who may be experiencing osteoporosis. Steroidal injections that were previously thought to be mostly safe may actually be weakening bones. The study suggests that they may possibly be increasing the risk of a painful and potentially deadly fracture by as much as 29 percent.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts